Lombard Odier Asset Management (USA) Corp - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 59 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.4%.

Quarter-by-quarter ownership
Lombard Odier Asset Management (USA) Corp ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2023$96,750
+39.7%
25,0000.0%0.00%0.0%
Q1 2023$69,250
-23.1%
25,000
-50.0%
0.00%0.0%
Q4 2022$90,000
-15.1%
50,0000.0%0.00%
-33.3%
Q3 2022$106,000
-21.5%
50,0000.0%0.00%
-40.0%
Q2 2022$135,000
-37.8%
50,0000.0%0.01%
-37.5%
Q1 2022$217,000
-16.2%
50,0000.0%0.01%
-20.0%
Q4 2021$259,000
-15.6%
50,0000.0%0.01%
-23.1%
Q3 2021$307,000
-39.2%
50,0000.0%0.01%
-35.0%
Q2 2021$505,00050,0000.02%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders